ropinirole

Known as: Ropinirol, 4-(2-(di-n-propylamino)ethyl)-2(3H)-indolone, ropinirole [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
CONTEXT An association between dopamine-replacement therapies and impulse control disorders (ICDs) in Parkinson disease (PD) has… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To evaluate the efficacy of ropinirole 24-hour prolonged release (ropinirole 24-hour) as an adjunct to levodopa in… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
In a 5-year, double-blind study, subjects with Parkinson's disease (PD) who were randomized to initial treatment with ropinirole… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Rotigotine is a new, non-ergot dopamine agonist formulated in a transdermal delivery system. The present study was to investigate… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE To assess the efficacy, safety, and tolerability of ropinirole in the treatment of patients with restless legs syndrome… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Preclinical studies suggest ropinirole (a D2/D3 dopamine agonist) may be neuroprotective in Parkinson's disease (PD), and a pilot… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND There is debate about whether the initial treatment for patients with Parkinson's disease should be levodopa or a… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The authors report a new side effect of the dopamine agonists pramipexole and ropinirole: sudden irresistible attacks of sleep… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
OBJECTIVE To evaluate the nonergot dopamine agonist ropinirole as an adjunct to L-dopa in a randomized, double-blind trial in PD… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
A prospective, randomized, placebo-controlled, double-blind, parallel-group, 6-month study assessed the efficacy and safety of… (More)
Is this relevant?